NeuroOne Medical Technologies Corporation NMTC 深 沪
等待开盘 10-10 09:30:00 美东时间
1.03
-0.010
-0.96%
华盛通- 最 高1.0897
- 今 开1.07
- 成交量 59.36万股
- 最 低 1.025
- 昨 收 1.04
- 总市值 5149.95万
- 52周最高 1.39
- 市盈率 静 --
- 换手率 1.19%
- 52周最低 0.3954
- 委 比 -12.52%
- 总股本 4999.95万
- 历史最高 7.97
- 量 比 0.75
- 振 幅 6.22%
- 历史最低 0.3954
- 每 手 1
- 风险率 0.18%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多NeuroOne Reports Record Revenue Growth for 2025
NeuroOne Medical Technologies ( ($NMTC) ) has issued an update. On October 6, 2...
10-07 04:51
NeuroOne Medical Technologies Reports Preliminary FY25 Results Of $9.1M Product Revenue And $6.6M Cash On Hand
Preliminary Results On October 6, 2024, the Company reported the following preliminary unaudited fiscal year 2025 financial and operational results: ●Achieved annual total product revenue of
10-07 04:40
Sidoti Events, LLC's Virtual September Small-Cap Conference
NEW YORK, NY / ACCESS Newswire / September 16, 2025 / Sidoti Events, LLC, an af...
09-16 23:20
美股大行评级 | 潜在涨幅577.08%！Veritone获D. Boral Capital升目标价至26美元，维持"买入"评级
今日重点评级关注：D. Boral Capital：维持Veritone"买入"评级，目标价从6美元升至26美元；Guggenheim：维持Dianthus Therapeutics"买入"评级，目标价从92美元升至100美元
09-10 18:01
Maxim Group Initiates Coverage On NeuroOne Medical Tech with Buy Rating, Announces Price Target of $3
Maxim Group analyst Anthony Vendetti initiates coverage on NeuroOne Medical Tech (NASDAQ:NMTC) with a Buy rating and announces Price Target of $3.
09-09 22:23
NeuroOne® to Participate in Sidoti Small-Cap Conference on September 17th and 18th, 2025
NeuroOne Medical Technologies Corporation will participate in the Sidoti & Co. Virtual Small-Cap Conference on September 17-18, 2025. CEO Dave Rosa and CFO Ron McClurg will present on September 17 at 12:15pm ET and host investor meetings. The company reported a 105% revenue increase to $1.7 million in Q3 2025 and a 53.9% gross margin, along with FDA clearance for its OneRF® system. NeuroOne aims to raise investor awareness and discuss growth oppo...
09-08 20:05
NeuroOne Gains FDA Clearance for Nerve Ablation System
NeuroOne Medical Technologies ( ($NMTC) ) has provided an announcement. On Augu...
08-18 20:58
NeuroOne® Receives FDA 510(k) Clearance for OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain
NeuroOne Medical Technologies Corporation received FDA clearance for its OneRF® Trigeminal Nerve Ablation System, enabling minimally invasive treatment of trigeminal neuralgia, a chronic pain condition affecting around 150,000 people annually. The system uses targeted radiofrequency energy to ablate trigeminal nerve fibers, offering a safer, more precise alternative to traditional pharmaceutical and surgical treatments. NeuroOne plans a limited c...
08-18 12:30
NeuroOne Updates Prospectus for $6.75 Million Offering
NeuroOne Medical Technologies ( ($NMTC) ) has provided an update. On December 2...
08-16 04:58
